Brief: Pharmiva Clinical Study PIVA01 Additionally Delayed

Pharmiva AB (publ)

05/11/2021 14:40

Nov 5 (Reuters) - Pharmiva AB (publ)  PHARM.ST :
    * CLINICAL STUDY PIVA01 IS ADDITIONALLY DELAYED
    * STUDY TO BE RESUMED IN JANUARY 2022
    * DELAY DOES NOT AFFECT THE COMPANY'S LAUNCH, RESULT REPORT
FROM
THE STUDY NOW EXPECTED AT THE END OF 2022

Source text for Eikon:  ID:nMFN5PyljY 
Further company coverage:  PHARM.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))